Neoplasms Malignant Clinical Trial
Official title:
Perceptions, Experiences, and Activity in CancEr Survivors During COVID-19
To examine perceptions and determinants of physical activity during the COVID-19 pandemic among cancer survivors.
This purpose of this study is to examine perceptions and determinants of physical activity during the COVID-19 pandemic in cancer survivors. To test our aim, we will recruit up to 1000 adults diagnosed with cancer within the last five years and ask them to complete an online questionnaire battery assessing their self-reported physical activity habits, psychosocial outcomes (e.g., depression, anxiety, self-efficacy, social support), and perceptions of physical activity engagement during the pandemic. A subsample of participants (n=50) will also be invited to participate in an interview to gain further insights into cancer survivors' physical activity experiences during COVID-19. Analysis of covariance (ANCOVA) will be used to analyze the quantitative survey data, and thematic analysis will be used to analyze the qualitative interview data. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT04047290 -
A Study of AK112, a PD-1/VEGF Bispecific Antibody, for Advanced Solid Tumors
|
Phase 1 | |
| Active, not recruiting |
NCT04600206 -
Existential Distress in Patients With Advanced Cancer and Their Caregivers
|
||
| Terminated |
NCT01243762 -
A Study of Dalotuzumab + MK-2206, Dalotuzumab + MK-0752, and Dalotuzumab + Ridaforolimus Combination Therapies in Participants With Advanced Cancer (MK-0646-027)
|
Phase 1 | |
| Completed |
NCT04728334 -
A Phase 1 Dose Escalation and Expansion Study of AK117
|
Phase 1 | |
| Terminated |
NCT01121588 -
An Investigational Drug, Crizotinib (PF-02341066), Is Being Studied In Tumors, Except Non-Small Cell Lung Cancer, That Are Positive For Anaplastic Lymphoma Kinase (ALK)
|
Phase 1 | |
| Recruiting |
NCT05939687 -
Prophylactic Mesh Placement During Stoma Closure After Low Anterior Resection
|
Phase 3 | |
| Recruiting |
NCT06018142 -
Clinical Application of Super-resolution Ultrasound(SR-US) Imaging in Solid Tumors
|
||
| Not yet recruiting |
NCT03903848 -
Cancer Survivors Acute Exercise Response 1
|
N/A | |
| Recruiting |
NCT05758571 -
Oxygen Atomizing Inhalation of EGCG in the Treatment Interstitial Pneumonia in Cancer Patients
|
Phase 1/Phase 2 | |
| Completed |
NCT04479579 -
Improved Adherence With Extended Venous Thromboembolism Prophylaxis After Major Cancer Surgery
|
Phase 4 | |
| Recruiting |
NCT04230772 -
Clinical Outcomes of NOSES Versus Traditional Robotic-assisted Surgery for Patients With Colorectal Cancer
|
N/A | |
| Not yet recruiting |
NCT05650385 -
A Study of B1962, a PD-L1/VEGF Bispecific Antibody Fusion Protein, for Advanced Solid Tumors
|
Phase 1 | |
| Completed |
NCT04616846 -
Thromboembolic Risk Screening in Patients With Cancer and COVID-19
|
N/A | |
| Completed |
NCT04349969 -
A Study to Evaluate the Safety, Pharmacokinetics, and Antitumor Activity of AK117 as Monotherapy or in Combination With AK104
|
Phase 1 | |
| Recruiting |
NCT04721756 -
Early Clinical Evaluation of 18F-LY3546117 in Tumor Imaging
|
Early Phase 1 |